PU
Pulmatrix, Inc.
PULM · NASDAQ
$1.48 -0.66% (-$0.01)
1M -11.46%
Market Cap $4.97M
P/E Ratio -
Div. Yield -
ROE 109.26%
Piotroski F-Score Weak
1/9Valuation
89 /100
Cheap P/B 1.94x
EV/FFO N/A
P/E N/A
Growth
0 /100
Declining Book val. growth 50.34%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 123.63%
ROIC 160.81%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 4.70x
Debt/Equity 0.00x
Debt/Assets N/A
Stability
31 /100
Unstable EPS volatility 9.22%
Beta 1.90x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PULM
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Peter Ludlum
Employees
2
Headquarters
Framingham
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report